These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 33371845)

  • 1. The Role of Nitro (NO
    Kamdem BP; Elizabeth FI
    Curr Drug Targets; 2021; 22(4):379-398. PubMed ID: 33371845
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Therapeutic Potential of Flavonoid Derivatives for Certain Neglected Tropical Diseases.
    Pone BK; Ferreira EI
    Curr Drug Targets; 2022; 23(7):680-682. PubMed ID: 35264087
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Flavonoids as efficient scaffolds: Recent trends for malaria, leishmaniasis, Chagas disease, and dengue.
    Boniface PK; Ferreira EI
    Phytother Res; 2019 Oct; 33(10):2473-2517. PubMed ID: 31441148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Exploring microalgal and cyanobacterial metabolites with antiprotozoal activity against Leishmania and Trypanosoma parasites.
    Matos ÂP; Saldanha-Corrêa FMP; Gomes RDS; Hurtado GR
    Acta Trop; 2024 Mar; 251():107116. PubMed ID: 38159713
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A Practical Green Synthesis and Biological Evaluation of Benzimidazoles Against Two Neglected Tropical Diseases: Chagas and Leishmaniasis.
    Bandyopadhyay D; Samano S; Villalobos-Rocha JC; Sanchez-Torres LE; Nogueda-Torres B; Rivera G; Banik BK
    Curr Med Chem; 2017; 24(41):4714-4725. PubMed ID: 23317160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quinoxaline derivatives as potential antitrypanosomal and antileishmanial agents.
    Cogo J; Cantizani J; Cotillo I; Sangi DP; Corrêa AG; Ueda-Nakamura T; Filho BPD; Martín JJ; Nakamura CV
    Bioorg Med Chem; 2018 Aug; 26(14):4065-4072. PubMed ID: 30100019
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthesis and biological evaluation of novel 2,3-disubstituted quinoxaline derivatives as antileishmanial and antitrypanosomal agents.
    Cogo J; Kaplum V; Sangi DP; Ueda-Nakamura T; Corrêa AG; Nakamura CV
    Eur J Med Chem; 2015 Jan; 90():107-23. PubMed ID: 25461316
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antitrypanosomal activity of 5-nitro-2-aminothiazole-based compounds.
    Papadopoulou MV; Bloomer WD; Rosenzweig HS; Wilkinson SR; Szular J; Kaiser M
    Eur J Med Chem; 2016 Jul; 117():179-86. PubMed ID: 27092415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vitro evaluation of arylsubstituted imidazoles derivatives as antiprotozoal agents and docking studies on sterol 14α-demethylase (CYP51) from Trypanosoma cruzi, Leishmania infantum, and Trypanosoma brucei.
    Rojas Vargas JA; López AG; Pérez Y; Cos P; Froeyen M
    Parasitol Res; 2019 May; 118(5):1533-1548. PubMed ID: 30903349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unveiling the Targets Involved in the Quest of Antileishmanial Leads Using In silico Methods.
    Boniface PK; Sano CM; Elizabeth FI
    Curr Drug Targets; 2020; 21(7):681-712. PubMed ID: 32003668
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diamidines as antitrypanosomal, antileishmanial and antimalarial agents.
    Werbovetz K
    Curr Opin Investig Drugs; 2006 Feb; 7(2):147-57. PubMed ID: 16499285
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Natural compounds based chemotherapeutic against Chagas disease and leishmaniasis: mitochondrion as a strategic target.
    Lazarin-Bidóia D; Garcia FP; Ueda-Nakamura T; Silva SO; Nakamura CV
    Mem Inst Oswaldo Cruz; 2022; 117():e220396. PubMed ID: 35352776
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Design and synthesis of a new series of 3,5-disubstituted isoxazoles active against Trypanosoma cruzi and Leishmania amazonensis.
    da Rosa R; de Moraes MH; Zimmermann LA; Schenkel EP; Steindel M; Bernardes LSC
    Eur J Med Chem; 2017 Mar; 128():25-35. PubMed ID: 28152426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Design, synthesis and antitrypanosomatid activity of 2-nitroimidazole-3,5-disubstituted isoxazole compounds based on benznidazole.
    Carvalho DB; Costa PAN; Portapilla GB; das Neves AR; Shiguemoto CYK; Pelizaro BI; Silva F; Piranda EM; Arruda CCP; Gaspari PDM; Cardoso IA; Luccas PH; Nonato MC; Lopes NP; de Albuquerque S; Baroni ACM
    Eur J Med Chem; 2023 Nov; 260():115451. PubMed ID: 37573209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Triazole-containing Heterocycles: Privileged Scaffolds in Anti-
    Pone KB; Dalhatou S; Paumo HK; Katata-Seru LM; Ferreira EI
    Curr Drug Targets; 2022; 23(1):33-59. PubMed ID: 33845739
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The role of natural anti-parasitic guided development of synthetic drugs for leishmaniasis.
    Pal R; Teli G; Akhtar MJ; Matada GSP
    Eur J Med Chem; 2023 Oct; 258():115609. PubMed ID: 37421889
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Repositioning FDA-Approved Drug Against Chagas Disease and Cutaneous Leishmaniosis by Structure-Based Virtual Screening.
    Juarez-Saldivar A; Gómez-Escobedo R; Corral-Ruiz G; Chacón-Vargas KF; Horta-Montaño V; Sanchez-Torres L; Vazquez-Jimenez LK; Nogueda-Torres B; Rivera G
    Arch Med Res; 2024 Feb; 55(2):102958. PubMed ID: 38290200
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Natural Products as a Source for Antileishmanial and Antitrypanosomal Agents.
    Scotti MT; Scotti L; Ishiki H; Ribeiro FF; Cruz RM; Oliveira MP; Mendonça FJ
    Comb Chem High Throughput Screen; 2016; 19(7):537-53. PubMed ID: 27682867
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Novel quinoxaline 1,4-di-N-oxide derivatives as new potential antichagasic agents.
    Torres E; Moreno-Viguri E; Galiano S; Devarapally G; Crawford PW; Azqueta A; Arbillaga L; Varela J; Birriel E; Di Maio R; Cerecetto H; González M; Aldana I; Monge A; Pérez-Silanes S
    Eur J Med Chem; 2013 Aug; 66():324-34. PubMed ID: 23811257
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High-throughput screening platform for natural product-based drug discovery against 3 neglected tropical diseases: human African trypanosomiasis, leishmaniasis, and Chagas disease.
    Annang F; Pérez-Moreno G; García-Hernández R; Cordon-Obras C; Martín J; Tormo JR; Rodríguez L; de Pedro N; Gómez-Pérez V; Valente M; Reyes F; Genilloud O; Vicente F; Castanys S; Ruiz-Pérez LM; Navarro M; Gamarro F; González-Pacanowska D
    J Biomol Screen; 2015 Jan; 20(1):82-91. PubMed ID: 25332350
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.